Login to Your Account

Word on the Street

Tuesday, December 27, 2011

"There will be a time when I recommend someone bringing an obesity product, but it's not going to be this decade."

Joshua Boger, retired founder and CEO of Vertex Pharmaceuticals Inc., talking about the increasing strictness of the FDA when it comes to risk-benefit analysis of drugs under review

"If you do a deal with somebody and it doesn't go well, you always want to be nice because it's a really, really small world."

John Fisher, founder of Biopsy Sciences Inc.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription